retatrutide human studies - GLP-1 / GIP / GCGR Tri-Agonist Retatrutide 10mg — Triple Agonist

The support and guidance Ive received have truly given me my life back

PMID: 52 Guillen-SamanderA.LeonzinoM.HannaM

dulaglutide, NEJM, 2025 Semaglutide and cartilage regeneration Cell Metabolism, 2026 Lean mass loss with GLP-1 drugs systematic review, 2024 Retatrutide Phase 2 NEJM, 2023 Myostatin gene discovery McPherron et al., Nature, 1997 German myostatin-knockout child Schuelke et al., NEJM, 2004 Myostatin inhibitor history Nielsen et al., Cells, 2021 Micronutrient joint advisory Mozaffarian et al., 2025 Last Updated on June 20, 2026 by Joe Garma

Your doctor will help adjust your treatment plan and evaluate the safety of any other medications youre taking

Anodyne Nanotech Anodyne Nanotech is one of the few pharmaceutical and drug delivery manufacturers with preclinical data on transdermal GLP-1 patches for obesity

Aim for 20-30 minutes per meal